410 related articles for article (PubMed ID: 27029486)
41. Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
Liu X; Yu R; Zhu L; Hou X; Zou K
Inflamm Bowel Dis; 2017 Oct; 23(10):1741-1751. PubMed ID: 28902123
[TBL] [Abstract][Full Text] [Related]
42. MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease.
Chen T; Xue H; Lin R; Huang Z
Biochem Biophys Res Commun; 2017 Apr; 486(1):6-13. PubMed ID: 28153728
[TBL] [Abstract][Full Text] [Related]
43. Talk about micromanaging! Role of microRNAs in intestinal barrier function.
Al-Sadi R; Engers J; Abdulqadir R
Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G170-G174. PubMed ID: 32658620
[TBL] [Abstract][Full Text] [Related]
44. No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases.
Malamut G; Cabane C; Dubuquoy L; Malapel M; Dérijard B; Gay J; Tamboli C; Colombel JF; Desreumaux P
Dig Dis Sci; 2006 Aug; 51(8):1443-53. PubMed ID: 16838116
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
46. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease.
Heimerl S; Moehle C; Zahn A; Boettcher A; Stremmel W; Langmann T; Schmitz G
Biochim Biophys Acta; 2006 Mar; 1762(3):341-50. PubMed ID: 16439103
[TBL] [Abstract][Full Text] [Related]
47. Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism.
Jiang XG; Sun K; Liu YY; Yan L; Wang MX; Fan JY; Mu HN; Li C; Chen YY; Wang CS; Han JY
Sci Rep; 2017 Feb; 7():41832. PubMed ID: 28150820
[TBL] [Abstract][Full Text] [Related]
48. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis.
Liu Y; Zhu F; Li H; Fan H; Wu H; Dong Y; Chu S; Tan C; Wang Q; He H; Gao F; Leng X; Zhou Q; Zhu X
Aging (Albany NY); 2020 Jul; 12(14):14966-14977. PubMed ID: 32713852
[TBL] [Abstract][Full Text] [Related]
49. Inhibiting microRNA-7 Expression Exhibited a Protective Effect on Intestinal Mucosal Injury in TNBS-Induced Inflammatory Bowel Disease Animal Model.
Guo J; Yang LJ; Sun M; Xu LF
Inflammation; 2019 Dec; 42(6):2267-2277. PubMed ID: 31494796
[TBL] [Abstract][Full Text] [Related]
50. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis.
Duijvis NW; Moerland PD; Kunne C; Slaman MMW; van Dooren FH; Vogels EW; de Jonge WJ; Meijer SL; Fluiter K; Te Velde AA
PLoS One; 2017; 12(10):e0185097. PubMed ID: 29059189
[TBL] [Abstract][Full Text] [Related]
52. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10.
Bai AH; Wu WK; Xu L; Wong SH; Go MY; Chan AW; Harbord M; Zhang S; Chen M; Wu JC; Chan MW; Chan MT; Chan FK; Sung JJ; Yu J; Cheng AS; Ng SC
J Crohns Colitis; 2016 Jun; 10(6):726-34. PubMed ID: 26802082
[TBL] [Abstract][Full Text] [Related]
53. Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis.
Lee J; Park EJ; Yuki Y; Ahmad S; Mizuguchi K; Ishii KJ; Shimaoka M; Kiyono H
Sci Rep; 2015 Dec; 5():18174. PubMed ID: 26647826
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
55. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples.
Boros É; Prontvai B; Kellermayer Z; Balogh P; Sarlós P; Vincze Á; Varga C; Maróti Z; Bálint B; Nagy I
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32610492
[TBL] [Abstract][Full Text] [Related]
56. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.
Zahm AM; Hand NJ; Tsoucas DM; Le Guen CL; Baldassano RN; Friedman JR
J Crohns Colitis; 2014 Sep; 8(9):1108-17. PubMed ID: 24613022
[TBL] [Abstract][Full Text] [Related]
57. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
Sakurai T; Kashida H; Watanabe T; Hagiwara S; Mizushima T; Iijima H; Nishida N; Higashitsuji H; Fujita J; Kudo M
Cancer Res; 2014 Nov; 74(21):6119-28. PubMed ID: 25187386
[TBL] [Abstract][Full Text] [Related]
58. Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets.
Rivera E; Flores I; Rivera E; Appleyard CB
Inflamm Bowel Dis; 2006 Oct; 12(10):950-66. PubMed ID: 17012966
[TBL] [Abstract][Full Text] [Related]
59. The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis.
Chinen I; Nakahama T; Kimura A; Nguyen NT; Takemori H; Kumagai A; Kayama H; Takeda K; Lee S; Hanieh H; Ripley B; Millrine D; Dubey PK; Nyati KK; Fujii-Kuriyama Y; Chowdhury K; Kishimoto T
Int Immunol; 2015 Aug; 27(8):405-15. PubMed ID: 25862525
[TBL] [Abstract][Full Text] [Related]
60. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice.
Wei Y; Lu C; Chen J; Cui G; Wang L; Yu T; Yang Y; Wu W; Ding Y; Li L; Uede T; Chen Z; Diao H
Oncotarget; 2017 Jan; 8(1):70-82. PubMed ID: 27926535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
